Fawzi A. Babiker
Kuwait City, KU, Kuwait
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents.
Journal: Biomolecules & biomedicine
Published: May 13, 2024
High-density lipoprotein protects normotensive and hypertensive rats against ischemia-reperfusion injury through differential regulation of mTORC1 and mTORC2 signaling.
Journal: Frontiers in pharmacology
Published: March 10, 2024
High-Density Lipoprotein Signaling via Sphingosine-1-Phosphate Receptors Safeguards Spontaneously Hypertensive Rats against Myocardial Ischemia/Reperfusion Injury.
Journal: Pharmaceutics
Published: February 20, 2024
Immunoglobulin-Mediated Cardiac Protection From Ischemia/Reperfusion Injury in Diabetic Rats Is Associated With Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway.
Journal: Journal of cardiovascular pharmacology
Published: January 04, 2024
Nitric Oxide/Glucose Transporter Type 4 Pathway Mediates Cardioprotection against Ischemia/Reperfusion Injury under Hyperglycemic and Diabetic Conditions in Rats.
Journal: Journal of vascular research
Published: December 06, 2023
Effects of Apocynin, a NADPH Oxidase Inhibitor, in the Protection of the Heart from Ischemia/Reperfusion Injury.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 17, 2023
Renin-Angiotensin System Antagonism Protects the Diabetic Heart from Ischemia/Reperfusion Injury in Variable Hyperglycemia Duration Settings by a Glucose Transporter Type 4-Mediated Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 12, 2022
Mitigating Cardiotoxicity of Dendrimers: Angiotensin-(1-7) via Its Mas Receptor Ameliorates PAMAM-Induced Cardiac Dysfunction in the Isolated Mammalian Heart.
Journal: Pharmaceutics
Published: October 28, 2022
Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 26, 2022
High Density Lipoprotein Reduces Blood Pressure and Protects Spontaneously Hypertensive Rats Against Myocardial Ischemia-Reperfusion Injury in an SR-BI Dependent Manner.
Journal: Frontiers in cardiovascular medicine
Published: November 30, 2021
Last Updated: 09/26/2026